πŸ‡ΊπŸ‡Έ FDA
Patent

US 9187453

Heterocyclic compound

granted A61KA61K31/506A61P

Quick answer

US patent 9187453 (Heterocyclic compound) held by Takeda Pharmaceutical Company Limited expires Mon Nov 12 2035 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
Takeda Pharmaceutical Company Limited
Grant date
Tue Nov 17 2015 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Nov 12 2035 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
6
CPC classes
A61K, A61K31/506, A61P, A61P1/04, A61P17/06